GABRB2 and schizophrenia: Thus recombination-selection co-occurrence would help to explain not only the association between GABRB2 S1-S29 segment with schizophrenia, but also the persistence of a high disease rate of 1% in humans despite the survival disadvantage of the disease, which is commonly recognized as the “central paradox” of schizophrenia [34].